Aclarion (ACON) Net Income towards Common Stockholders (2021 - 2026)
Aclarion (ACON) posted Net Income towards Common Stockholders of -$2.9 million for Q1 2026, down 51.05% on a QoQ basis from -$1.9 million in Q4 2025, and down 39.6% year-over-year from -$4.7 million in Q1 2025.
Aclarion (ACON) Net Income towards Common Stockholders (2021 - 2026) Analysis & Trends
Aclarion's Net Income towards Common Stockholders history runs 6 years deep, the most recent figure standing at -$2.9 million for Q1 2026.
- Quarterly Net Income towards Common Stockholders fell 39.6% year-over-year to -$2.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$8.0 million (down 20.19% YoY) and the FY2025 annual result came in at -$7.2 million, down 2.66% from the prior year.
- Net Income towards Common Stockholders was -$2.9 million for Q1 2026 at Aclarion, down from -$1.9 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at -$944610.0 in Q4 2022 and bottomed at -$3.7 million in Q2 2022.
- A 5-year average of -$1.7 million and a median of -$1.6 million in 2025 frame the typical range for Net Income towards Common Stockholders.
- Annual changes were most pronounced in 2022 — Net Income towards Common Stockholders sank 442.62% — and 2023, when it jumped 60.24%.
- Aclarion's Net Income towards Common Stockholders stood at -$944610.0 in 2022, then plunged by 33.95% to -$1.3 million in 2023, then sank by 60.99% to -$2.0 million in 2024, then grew by 7.26% to -$1.9 million in 2025, then slumped by 51.05% to -$2.9 million in 2026.
- Business Quant data shows ACON's Net Income towards Common Stockholders at -$2.9 million in Q1 2026, -$1.9 million in Q4 2025, and -$1.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 32.15 Bn | 24.84 Bn | 662.02 Mn | 260.94 Mn |
| 2 | BrightSpring Health Services | 14.66 Bn | 13.75 Bn | 482.22 Mn | 148.77 Mn |
| 3 | Healthequity | 8.39 Bn | 8.13 Bn | 256.31 Mn | 69.42 Mn |
| 4 | Hinge Health | 5.95 Bn | 5.64 Bn | 154.23 Mn | 34.01 Mn |
| 5 | 10x Genomics | 5.88 Bn | 5.34 Bn | 106.18 Mn | -13.47 Mn |
| 6 | MiniMed | 4.53 Bn | 4.23 Bn | 480.00 Mn | -185.00 Mn |
| 7 | Waystar Holding | 4.46 Bn | 4.40 Bn | 216.84 Mn | 43.28 Mn |
| 8 | Doximity | 3.96 Bn | 3.21 Bn | 125.97 Mn | 19.11 Mn |
| 9 | Privia Health | 3.13 Bn | 2.71 Bn | - | 3.71 Mn |
| 10 | Aclarion | 4.71 Mn | 4.71 Mn | 3,750.00 | -2.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.85 Mn |
| Dec 31, 2025 | -1.89 Mn |
| Sep 30, 2025 | -1.71 Mn |
| Jun 30, 2025 | -1.60 Mn |
| Mar 31, 2025 | -2.04 Mn |
| Dec 31, 2024 | -2.04 Mn |
| Sep 30, 2024 | -1.38 Mn |
| Jun 30, 2024 | -1.24 Mn |
| Mar 31, 2024 | -2.40 Mn |
| Dec 31, 2023 | -1.27 Mn |
| Sep 30, 2023 | -998,010.00 |
| Jun 30, 2023 | -1.46 Mn |
| Mar 31, 2023 | -1.18 Mn |
| Dec 31, 2022 | -944,610.00 |
| Sep 30, 2022 | -1.63 Mn |
| Jun 30, 2022 | -3.68 Mn |
| Mar 31, 2022 | -1.22 Mn |
| Dec 31, 2021 | -1.30 Mn |
| Sep 30, 2021 | -3.24 Mn |
| Jun 30, 2021 | -678,763.00 |